Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.
about
Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunityIdentification of novel epitopes from human papillomavirus type 18 E7 that can sensitize PBMCs of multiple HLA class I against human cervical cancer.Vaccines against cancer: Despite setbacks, attempts to harness the patient's immune system to fight tumor cells show promise in clinical trialsAntitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems.A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer.Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.Human papillomavirus vaccination: where are we now?Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Therapeutic vaccines for high-risk HPV-associated diseases.The Impact of HPV as an Etiological Factor in Gynecological and Oropharyngeal CancerThe Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q34033407-0FF7B9AE-10C5-450A-B116-0ADBB6C5FD22Q34091377-FB05164B-76DB-4413-9226-0322A92371E7Q34407946-0D141135-464B-4EF6-9140-A277833653E6Q34544509-4D79E57D-6EE0-4037-BAD2-268B1C74C37BQ36188919-E9B909B2-E999-49D8-A76A-1EEB7F2EFBCEQ36310924-DA5423CE-0450-44AD-AFFF-473780A90EF2Q36711018-E90E9855-C293-4E98-9639-26528DE81E61Q36757129-F1C2344A-C6D6-4332-B2D1-279804075AF3Q36788317-25921F82-1F92-4320-AB8E-971023E9D82FQ38218612-0156FF81-772D-4E88-8856-C7AD6CC5EE2DQ40097092-616A6713-0CCA-485F-80A8-982A59A1FFAFQ41435861-64D7A0A3-2D96-4E00-87B1-EF8E856EFEFCQ47255618-9B9FEBA6-B31C-480E-A286-A49866138CDAQ57028715-A25B7BC7-A136-436C-ACCF-7C9FFC060E11Q58750585-507618E0-3DA7-416D-9B5A-E101156726A6
P2860
Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Human papillomavirus therapeut ...... ecancerous disease and cancer.
@en
type
label
Human papillomavirus therapeut ...... ecancerous disease and cancer.
@en
prefLabel
Human papillomavirus therapeut ...... ecancerous disease and cancer.
@en
P2860
P356
P1476
Human papillomavirus therapeut ...... recancerous disease and cancer
@en
P2093
Matthew P Morrow
P2860
P304
P356
10.1586/ERV.13.23
P577
2013-03-01T00:00:00Z